目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.1.1 MARKET SYPNOSIS

2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING DEMAND FOR FACIAL AESTHETICS GLOBALLY
4.2.2 INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS
4.2.3 COST-EFFECTIVE ALTERNATIVE TO COSMETIC SURGERIES
4.3 RESTRAINTS
4.3.1 SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS
4.3.2 BLACK MARKET OF DERMAL FILLERS AND EFFECTS OF UNREGISTERED PRACTITIONERS
4.4 OPPORTUNITIES
4.4.1 INCREASING NUMBER OF CLINICAL TRIAL STUDIES
4.4.2 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES

5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 MARKETING AND DISTRIBUTION
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL DERMAL FILLERS MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON DEMAND AND SUPPLY
5.3.3 IMPACT ON REGIONS

6 GLOBAL DERMAL FILLERS MARKET, BY TYPE
6.1 OVERVIEW
6.2 HYALURONIC ACID
6.3 CALCIUM HYDROXYLAPATITE
6.4 POLY-L-LACTIC ACID
6.5 OTHERS

7 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 FACIAL LINE CORRECTION
7.3 FACE LIFT
7.4 LIP ENHANCEMENT
7.5 OTHERS

8 GLOBAL DERMAL FILLERS MARKET, BY END USER
8.1 OVERVIEW
8.2 SPECIALTY & DERMATOLOGY CLINICS
8.3 HOSPITALS
8.4 OTHERS

9 GLOBAL DERMAL FILLERS MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 INDIA
9.4.3 JAPAN
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST
9.5.2 AFRICA
9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL DERMAL FILLERS MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL DERMAL FILLERS MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 ACQUISITION
10.6.2 PRODUCT APPROVAL AND LAUNCH
10.6.3 EXPANSION
10.6.4 PARTNERSHIP/AGREEMENT

11 COMPANY PROFILES
11.1 ABBVIE INC.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 ABBVIE INC.: KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 DR. KORMAN LABORATORIES
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 TEOXANE LABORATORIES
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 SCIVISION BIOTECH INC.
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 BRIDGEPOINT GROUP PLC
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 GALDERMA LABORATORIES, L.P
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 MERZ PHARMA
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 SINCLAIR PHARMA
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 SUNEVA MEDICAL
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 MEDYTOX
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES

12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 GLOBAL DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY REGION, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY REGION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL DERMAL FILLERS MARKET, FOR POLY-L-LACTIC ACID, BY REGION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL DERMAL FILLERS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 7 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 GLOBAL DERMAL FILLERS MARKET, FOR FACIAL LINE CORRECTION, BY REGION, 2019-2032 (USD BILLION)
TABLE 9 GLOBAL DERMAL FILLERS MARKET, FOR FACE LIFT, BY REGION, 2019-2032 (USD BILLION)
TABLE 10 GLOBAL DERML FILLERS MARKET, FOR LIP ENHANCEMENT, BY REGION, 2019-2032 (USD BILLION)
TABLE 11 GLOBAL DERMAL FILLERS MARKET, FOR OTHERS, BY ERGION, 2019-2032 (USD BILLION)
TABLE 12 GLOBAL DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 GLOBAL DERMAL FILLERS MARKET, FOR SPECIALTY & DERMATOLOGY CLINICS, BY REGION, 2019-2032 (USD BILLION)
TABLE 14 GLOBAL DERMAL FILLERS MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD BILLION)
TABLE 15 GLOBAL DERMAL FILLERS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 16 GLOBAL DERMAL FILLERS MARKET, BY REGION, 2019-2032 (USD BILLION)
TABLE 17 GLOBAL DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 18 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 19 GLOBAL DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 20 NORTH AMERICA: DERMAL FILLERS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 21 NORTH AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 22 NORTH AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 23 NORTH AMERICA: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 24 US: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 25 US: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 26 US: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 27 CANADA: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 28 CANADA: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 29 CANADA: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 30 EUROPE: DERMAL FILLERS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 31 EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 32 EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 EUROPE: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 34 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 35 GERMANY: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 GERMANY: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 37 UK: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 38 UK: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 39 UK: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 40 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 41 FRANCE: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 FRANCE: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 43 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 44 ITALY: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 ITALY: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 46 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 47 SPAIN: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 SPAIN: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 49 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 50 REST OF EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 51 REST OF EUROPE: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 52 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 53 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 54 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 55 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 56 CHINA: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 57 CHINA: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 58 CHINA: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 59 INDIA: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 60 INDIA: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 61 INDIA: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 62 JAPAN: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 63 JAPAN: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 64 JAPAN: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 65 AUSTRALIA: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 66 AUSTRALIA: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 67 AUSTRALIA: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 68 SOUTH KOREA: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 69 SOUTH KOREA: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 70 SOUTH KOREA: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 71 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 72 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 73 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 74 REST OF THE WORLD: DERMAL FILLERS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 75 REST OF THE WORLD: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 76 REST OF THE WORLD: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 77 REST OF THE WORLD: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 78 MIDDLE EAST: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 79 MIDDLE EAST: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 80 MIDDLE EAST: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 81 AFRICA: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 82 AFRICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 83 AFRICA: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 84 LATIN AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 85 LATIN AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 86 LATIN AMERICA: DERMAL FILLERS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 87 MAJOR PLAYERS IN THE GLOBAL DERMAL FILLERS MARKET
TABLE 88 MOST ACTIVE PLAYER IN THE GLOBAL DERMAL FILLERS MARKET
TABLE 89 ACQUISITION: GLOBAL DERMAL FILLERS MARKET
TABLE 90 PRODUCT APPROVAL AND LAUNCH: GLOBAL DERMAL FILLERS MARKET
TABLE 91 EXPANSION: GLOBAL DERMAL FILLERS MARKET
TABLE 92 PARTNERSHIP/AGREEMENT: GLOBAL DERMAL FILLERS MARKET
TABLE 93 ABBVIE INC.: PRODUCTS OFFERED
TABLE 94 ABBVIE INC.: KEY DEVELOPMENTS
TABLE 95 DR. KORMAN LABORATORIES: PRODUCTS OFFERED
TABLE 96 TEOXANE LABORATORIES: PRODUCTS OFFERED
TABLE 97 TEOXANE LABORATORIES: KEY DEVELOPMENTS
TABLE 98 SCIVISION BIOTECH INC.: PRODUCTS OFFERED
TABLE 99 BRIDGEPOINT GROUP PLC: PRODUCTS OFFERED
TABLE 100 GALDERMA LABORATORIES, L.P: PRODUCTS OFFERED
TABLE 101 GALDERMA LABORATORIES, L.P: KEY DEVELOPMENTS
TABLE 102 MERZ PHARMA: PRODUCTS OFFERED
TABLE 103 MERZ PHARMA: KEY DEVELOPMENTS
TABLE 104 SINCLAIR PHARMA: PRODUCTS OFFERED
TABLE 105 SINCLAIR PHARMA: KEY DEVELOPMENTS
TABLE 106 SUNEVA MEDICAL: PRODUCTS OFFERED
TABLE 107 SUNEVA MEDICAL: KEY DEVELOPMENTS
TABLE 108 MEDYTOX: PRODUCTS OFFERED

LIST OF FIGURES
FIGURE 1 GLOBAL DERMAL FILLERS MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL DERMAL FILLERS MARKET
FIGURE 4 DRIVERS IMPACT ANALYSIS
FIGURE 5 RESTRAINTS IMPACT ANALYSIS
FIGURE 6 VALUE CHAIN: GLOBAL DERMAL FILLERS MARKET
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DERMAL FILLERS MARKET
FIGURE 8 GLOBAL DERMAL FILLERS MARKET, TYPE SEGMENT ATTRACTIVENESS, (USD BILLION)
FIGURE 9 GLOBAL DERMAL FILLERS MARKET, BY TYPE, 2022 & 2032 (USD BILLION)
FIGURE 10 GLOBAL DERMAL FILLERS MARKET SHARE (%), BY TYPE, 2022
FIGURE 11 GLOBAL DERMAL FILLERS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, (USD BILLION)
FIGURE 12 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION)
FIGURE 13 GLOBAL DERMAL FILLERS MARKET SHARE (%), BY APPLICATION, 2022
FIGURE 14 GLOBAL DERMAL FILLERS MARKET, END USER SEGMENT ATTRACTIVENESS, (USD BILLION)
FIGURE 15 GLOBAL DERMAL FILLERS MARKET, BY END USER, 2022 & 2032 (USD BILLION)
FIGURE 16 GLOBAL DERMAL FILLERS MARKET SHARE (%), BY END USER, 2022
FIGURE 17 GLOBAL DERMAL FILLERS MARKET SHARE (%), BY REGION, 2022
FIGURE 18 GLOBAL DERMAL FILLERS MARKET, BY REGION, 2022 & 2032 (USD BILLION)
FIGURE 19 NORTH AMERICA MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019-2032 (USD BILLION)
FIGURE 20 NORTH AMERICA: DERMAL FILLERS MARKET SHARE (%), BY REGION, 2022
FIGURE 21 EUROPE MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019-2032 (USD BILLION)
FIGURE 22 EUROPE: DERMAL FILLERS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019-2032 (USD BILLION)
FIGURE 24 ASIA-PACIFIC: DERMAL FILLERS MARKET SHARE (%), BY REGION, 2022
FIGURE 25 REST OF THE WORLD MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019-2032 (USD BILLION)
FIGURE 26 REST OF THE WORLD: DERMAL FILLERS MARKET SHARE (%), BY REGION, 2022
FIGURE 27 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 28 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL DERMAL FILLERS MARKET
FIGURE 29 GLOBAL DERMAL FILLERS MARKET: COMPETITIVE LANDSCAPE
FIGURE 30 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ABBVIE INC.: SWOT ANALYSIS
FIGURE 32 DR. KORMAN LABORATORIES: SWOT ANALYSIS
FIGURE 33 TEOXANE LABORATORIES: SWOT ANALYSIS
FIGURE 34 GALDERMA LABORATORIES, L.P.: SWOT ANALYSIS
FIGURE 35 MERZ PHARMA: SWOT ANALYSIS
FIGURE 36 SINCLAIR PHARMA: FINANCIAL OVERVIEW SNAPSHOT